Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada

por Mtibaa, Mondher, Gupta, Subhajit, Muthukumar, Madhusubramanian, Marvel, Jessica, Kaur, Harneet, Ishikawa, Ryotaro, Olivenstein, Ron
Publicado 2021

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

por Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason
Publicado 2017